Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure
Objective: To analyze the effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as connective tissue growth factor (CTGF) and transforming growth factor (TGF)-β1 content in patients with chronic renal failure. Methods: 80 patients with ch...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2017-01-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201701/17.pdf |
id |
doaj-bb9a67b049b84e558f44d2e4d9a404e6 |
---|---|
record_format |
Article |
spelling |
doaj-bb9a67b049b84e558f44d2e4d9a404e62020-11-25T00:11:27ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12372017-01-012316467Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failureHai-Yu Guan0Nephrology Department, TCM-Integrated Hospital of Southern Medical University, Haizhu District, Guangzhou 510315, ChinaObjective: To analyze the effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as connective tissue growth factor (CTGF) and transforming growth factor (TGF)-β1 content in patients with chronic renal failure. Methods: 80 patients with chronic renal insufficiency treated in our hospital between March 2013 and March 2016 were selected for study and randomly divided into observation group (n=40) and control group (n=40). Control group received conventional therapy and observation group received conventional + adjuvant salvia miltiorrhiza and ligustrazine therapy. After 3 months of treatment, differences in renal function indexes, illness-related indexes, renal blood perfusion, CTGF and TGF-β1 content, and so on of two groups of patients were determined. Results: After 3 months of treatment, serum urea nitrogen (BUN), serum creatinine (Scr), β2 microglobulin (β2-MG), intermedin (IMD), fibroblast growth factor 23 (FGF23), cystatin C (CysC), CTGF and TGF-β1 content as well as 24 h urine albumin excretion rate (UAER) level in urine of observation group were significantly lower than those of control group (P<0.05) while glomerular filtration rate (GFR) level and serum adiponectin (APN) content were significantly higher than those of control group (P<0.05); renal perfusion parameters renal cortex Tmax (ATc) and medulla Tmax (ATm) levels of observation group were significantly lower than those of control group while cortex peak intensity change (ΔAc), medulla peak intensity change (ΔAm) and peak intensity (PI) levels were significantly higher than those of control group. Conclusions: Adjuvant salvia miltiorrhiza and ligustrazine therapy can effectively control the overall condition of patients with chronic renal failure, and plays a positive role in improving renal function and increasing renal blood perfusion.http://www.hnykdxxb.com/PDF/201701/17.pdfChronic renal failureSalvia miltiorrhiza and ligustrazinetherapyRenal functionRenal blood perfusion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hai-Yu Guan |
spellingShingle |
Hai-Yu Guan Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure Journal of Hainan Medical University Chronic renal failure Salvia miltiorrhiza and ligustrazine therapy Renal function Renal blood perfusion |
author_facet |
Hai-Yu Guan |
author_sort |
Hai-Yu Guan |
title |
Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure |
title_short |
Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure |
title_full |
Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure |
title_fullStr |
Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure |
title_full_unstemmed |
Effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as CTGF and TGF-β1 content in patients with chronic renal failure |
title_sort |
effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on renal function, renal blood perfusion as well as ctgf and tgf-β1 content in patients with chronic renal failure |
publisher |
Editorial Board of Journal of Hainan Medical University |
series |
Journal of Hainan Medical University |
issn |
1007-1237 |
publishDate |
2017-01-01 |
description |
Objective: To analyze the effect of adjuvant salvia miltiorrhiza and ligustrazine therapy on
renal function, renal blood perfusion as well as connective tissue growth factor (CTGF) and
transforming growth factor (TGF)-β1 content in patients with chronic renal failure. Methods:
80 patients with chronic renal insufficiency treated in our hospital between March 2013 and
March 2016 were selected for study and randomly divided into observation group (n=40)
and control group (n=40). Control group received conventional therapy and observation
group received conventional + adjuvant salvia miltiorrhiza and ligustrazine therapy. After 3
months of treatment, differences in renal function indexes, illness-related indexes, renal blood
perfusion, CTGF and TGF-β1 content, and so on of two groups of patients were determined.
Results: After 3 months of treatment, serum urea nitrogen (BUN), serum creatinine (Scr),
β2 microglobulin (β2-MG), intermedin (IMD), fibroblast growth factor 23 (FGF23),
cystatin C (CysC), CTGF and TGF-β1 content as well as 24 h urine albumin excretion rate
(UAER) level in urine of observation group were significantly lower than those of control
group (P<0.05) while glomerular filtration rate (GFR) level and serum adiponectin (APN)
content were significantly higher than those of control group (P<0.05); renal perfusion
parameters renal cortex Tmax (ATc) and medulla Tmax (ATm) levels of observation group
were significantly lower than those of control group while cortex peak intensity change (ΔAc),
medulla peak intensity change (ΔAm) and peak intensity (PI) levels were significantly higher
than those of control group. Conclusions: Adjuvant salvia miltiorrhiza and ligustrazine therapy
can effectively control the overall condition of patients with chronic renal failure, and plays a
positive role in improving renal function and increasing renal blood perfusion. |
topic |
Chronic renal failure Salvia miltiorrhiza and ligustrazine therapy Renal function Renal blood perfusion |
url |
http://www.hnykdxxb.com/PDF/201701/17.pdf |
work_keys_str_mv |
AT haiyuguan effectofadjuvantsalviamiltiorrhizaandligustrazinetherapyonrenalfunctionrenalbloodperfusionaswellasctgfandtgfb1contentinpatientswithchronicrenalfailure |
_version_ |
1725403884293193728 |